LANGHOLM MEDICAL PARTNERSHIP
Langholm Medical Partnership, Health Centre, Langholm, DG13 0JY
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | None | None | NA% | |
| HF 4 | 2011 | 0 | 0 | NA% | |
| HF 4 | 2012 | 4 | 5 | 80.0% | |
| HF 4 | 2013 | 5 | 6 | 83.3% | |
| HF004(S) | 2014 | None | None | NA% | |
| HF004(S) | 2015 | None | None | NA% | |
| HF004(S) | 2016 | 7 | 8 | 87.5% |
